Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02194582 · ClinicalTrials.gov registry record

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

A clinical trial of End Stage Renal Disease and Focal Segmental Glomerulosclerosis, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
2,050
Enrollment target
1
Study location

NCT02194582 is a study of End Stage Renal Disease and Focal Segmental Glomerulosclerosis that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 2,050 participants, above the 810-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (153% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02194582, a study of End Stage Renal Disease and Focal Segmental Glomerulosclerosis, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
2,050 participants
Enrollment target
1
Study location

Study Summary

The investigators are trying to learn more about the cause of kidney diseases such as Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic syndrome by studying genetics. The investigators are interested in discovering which genes play a role in causing a predisposition to FSGS/NS. The investigators also want to learn why FSGS/NS can run in families. Participation in our study involves a saliva sample and a urine sample that you can give from home. There is no cost to participate. All information is kept private and confidential. The investigators also like to include healthy volunteers (parents, spouses) if interested/available but of course this is completely optional.

Conditions Studied

End Stage Renal Disease Focal Segmental Glomerulosclerosis Kidney Failure Nephrotic Syndrome Unexplained Proteinuria

Study Locations (1)

Massachusetts

  • BIDMC - Boston

Trial Details

FieldValue
Enrollment Target 2,050 participants
Start Date 1996-06
Est. Completion 2035-01

Sponsor

Beth Israel Deaconess Medical Center

488 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02194582

The ClinicalTrials.gov registry entry for NCT02194582 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,050 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 810-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (153% higher). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02194582 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02194582 about?

NCT02194582 is a clinical study titled "Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure". The investigators are trying to learn more about the cause of kidney diseases such as Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic syndrome by studying genetics. The investigators are interested in discovering which genes play a role in causing a predisposition to FSGS/NS. The investigato...

What is the current status of trial NCT02194582?

This trial is currently active not recruiting. The enrollment target is 2,050 participants. The study started on 1996-06. Estimated completion is 2035-01.

What conditions does trial NCT02194582 study?

This clinical trial studies the following conditions: End Stage Renal Disease, Focal Segmental Glomerulosclerosis, Kidney Failure, Nephrotic Syndrome, Unexplained Proteinuria.

Who is sponsoring clinical trial NCT02194582?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02194582 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Focal Segmental Glomerulosclerosis

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.